| Intestinal Diseases |
| Active, not recruiting | 3 | 95000 | US, Europe, RoW | Colonoscopy | Oslo University Hospital, Maria Sklodowska-Curie National Research Institute of Oncology, Erasmus Medical Center, Landspitali University Hospital, Uppsala University Hospital, Karolinska Institutet, Memorial Sloan Kettering Cancer Center, Harvard School of Public Health (HSPH) | Colorectal Cancer | 06/26 | 07/36 | | |
NCT02349984: Recombinant Anti-tumor and Anti-virus Protein for Injection in Treatment of Metastatic Colorectal Cancer |
|
|
| Recruiting | 2/3 | 105 | RoW | Recombinant anti-tumor and anti-virus protein for injection, Novaferon, Saline Injection, Brand name: Novaferon | Beijing Genova Biotech Company, Ltd. | Metastatic Colorectal Cancer | 05/15 | 05/15 | | |
NCT01790061: Standardized Fecal Microbiota Transplantation for Ulcerative Colitis |
|
|
| Recruiting | 2/3 | 500 | RoW | Standardized FMT, Fecal Microbiota Transplantation, Fecal Microbiota Therapy, fecal transplantation, Traditional treatments, Traditional treatments according to associated guidelines | The Second Hospital of Nanjing Medical University, Air Force Military Medical University, China | Bacteria, Microbiota, Fecal Microbiota Transplantation, Inflammatory Bowel Disease, Ulcerative Colitis | 12/25 | 12/25 | | |
NCT01322542: YF476 in Patients With Type II Gastric Carcinoids Associated With Zollinger-Ellison Syndrome |
|
|
| Recruiting | 2 | 30 | US | YF476 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Carcinoid | 12/17 | 12/17 | | |
| Recruiting | 2 | 100 | Europe | Bevacizumab plus alternating Xelox/Xeliri, Avastin, Xeloda, irinotecan, oxaliplatin | Pia Osterlund | Metastatic Colorectal Cancer | 12/25 | 12/25 | | |
HyRec, NCT01716949: Neoadjuvant Chemoradiation With 5-FU(or Capecitabine) and Oxaliplatin Combined With Hyperthermia in Rectal Cancer |
|
|
| Recruiting | 1/2 | 59 | Europe | Radiotherapy, Hyperthermia, 5-Fluorouracil, all brands of 5-Fluorouracil are allowed, Capecitabine, all brands of Capecitabine are allowed, Oxaliplatin, all brands of oxaliplatin are allowed | University of Erlangen-Nürnberg Medical School | Rectal Cancer | 06/22 | 06/23 | | |
NCT00436735: Nelfinavir in Treating Patients With Metastatic, Refractory, or Recurrent Solid Tumors |
|
|
| Active, not recruiting | 1 | 45 | US | midazolam hydrochloride, nelfinavir mesylate, gene expression analysis, polymerase chain reaction, protein expression analysis, immunoenzyme technique, immunologic technique, laboratory biomarker analysis, mass spectrometry | National Cancer Institute (NCI) | Colorectal Cancer, Gastrointestinal Carcinoid Tumor, Head and Neck Cancer, Islet Cell Tumor, Lung Cancer, Metastatic Cancer, Neuroendocrine Carcinoma of the Skin, Ovarian Cancer, Pheochromocytoma, Sarcoma, Unspecified Adult Solid Tumor, Protocol Specific | | | | |
NCT00511771: A Treatment Investigational New Drug (tIND) Program of Tegaserod in Women With Irritable Bowel Syndrome With Constipation or With Chronic Idiopathic Constipation |
|
|
| No Longer Available | N/A | | US | Tegaserod, Zelnorm | Novartis | Irritable Bowel Syndrome With Constipation, Chronic Idiopathic Constipation | | | | |
| Active, not recruiting | N/A | 530 | Europe | Appendicectomy, Ertapenem | Turku University Hospital, Oulu University Hospital, Tampere University Hospital, Mikkeli Central Hospital, Jyväskylä Central Hospital, Seinajoki Central Hospital | Acute Appendicitis | 06/12 | 12/25 | | |
NCT02347800: The Effect of Daratumumab on the Suppressive Function of Myeloid Derived Suppressor Cells (MDSCs) on T Cells |
|
|
| Recruiting | N/A | 25 | US | Blood draw | University of Pennsylvania | Colorectal Cancer, Colon Cancer | 01/16 | 01/16 | | |
| Active, not recruiting | N/A | 280 | Europe | Open liver resection, Open liver resection using standard technique:, Ligasure, CUSA, Thunderbeat, Autosonix, SonoSurg, Ultrasound, Laparoscopic liver resection, Laparoscopic liver resection using standardized technique:, Laparoscopic ultrasound | Oslo University Hospital, Helse Sor-Ost | Secondary Malignant Neoplasm of Liver, Colorectal Neoplasms | 04/16 | 12/25 | | |
NCT02321488: Patient Centered Outcomes Research Institute (PCORI) Provider Survey on Treatment Eligibility |
|
|
| Recruiting | N/A | 120 | US | Survey, Questionnaire | M.D. Anderson Cancer Center, Patient-Centered Outcomes Research Institute | Colorectal Cancer | 12/17 | | | |
NCT01371591: Capsule Endoscopy for Hemorrhage in the Emergency Room |
|
|
| Not yet recruiting | N/A | 100 | US | Pill Cam, clinical evaluation, Video Capsule Endoscopy (VCE), Pill Cam, archived | Andrew Meltzer, Medtronic | Melena, Hematemesis, Peptic Ulcer Hemorrhage, Variceal Hemorrhage | 08/18 | 08/18 | | |
NCT02164136: Laparoscopic Versus Open PANP-TME for Male Mid-low Rectal Cancer Patients |
|
|
| Recruiting | N/A | 172 | RoW | L-PANP-TME, O-PANP-TME | Third Affiliated Hospital, Sun Yat-Sen University | Rectum Neoplasms | 06/19 | 06/23 | | |
NCT02165800: Multicenter Study on Laparoscopic Versus Open PANP-TME for Male Mid-low Rectal Cancer Patients |
|
|
| Recruiting | N/A | 667 | RoW | L-PANP-TME, O-PANP-TME | Third Affiliated Hospital, Sun Yat-Sen University, First Affiliated Hospital, Sun Yat-Sen University, Sixth Affiliated Hospital, Sun Yat-sen University, Nanfang Hospital of Southern Medical University, Southern Medical University, China | Rectum Neoplasms | 12/19 | 12/23 | | |
| Completed | N/A | 235 | Europe | FOLFOX, FOLFOX-4 or equivalent | Jules Bordet Institute | Colon Cancer | 12/22 | 12/22 | | |
HAEC, NCT02193685: Identification Genetic, Immunologic and Microbial Markers of Hirschsprung Associated Enterocolitis in Children With Hirschsprung Disease |
|
|
| Recruiting | N/A | 400 | US | | Cedars-Sinai Medical Center, Karolinska University Hospital, Children's Hospital Los Angeles, UCSF Benioff Children's Hospital Oakland, University of Michigan, The University of Texas Health Science Center, Houston | Hirschsprung Disease, Enterocolitis | 12/22 | 12/25 | | |
| Recruiting | N/A | 600 | Europe | | Maastricht University Medical Center | Irritable Bowel Syndrome | 09/24 | 09/24 | | |
| Recruiting | N/A | 1000 | Europe | Biomarker sampling | Pia Osterlund | Metastatic Colorectal Cancer | 12/25 | 12/25 | | |
NCT01793831: Standardized Fecal Microbiota Transplantation for Crohn&Apos;s Diseases |
|
|
| Recruiting | N/A | 200 | RoW | FMT | The Second Hospital of Nanjing Medical University, Air Force Military Medical University, China | Crohn's Diseases, Inflammatory Bowel Disease | 12/25 | 12/25 | | |
| Not yet recruiting | N/A | 2500 | RoW | | Tel-Aviv Sourasky Medical Center | Inflammatory Bowel Disease | 12/26 | 12/26 | | |
NCT01199250: Biomarkers in Samples From Patients With Endometrial Cancer |
|
|
| Not yet recruiting | N/A | 3600 | US | Laboratory Biomarker Analysis | Gynecologic Oncology Group, National Cancer Institute (NCI) | Lynch Syndrome, Recurrent Uterine Corpus Carcinoma, Stage I Uterine Corpus Cancer, Stage II Uterine Corpus Cancer, Stage III Uterine Corpus Cancer, Stage IV Uterine Corpus Cancer | 01/00 | | | |